Table 2 Comparison of study groups in terms of Myelin degeneration
Absent | Mild | Severe | |
|---|---|---|---|
Control (n = 10) | 0 | 7 | 3 |
Magnesium sulfate (n = 10) | 0 | 7 | 3 |
Ketamine (n = 10) | 0 | 9 | 1 |
Dexmedetomidine (n = 10) | 3 | 7 | 0 |
Absent | Mild | Severe | |
|---|---|---|---|
Control (n = 10) | 0 | 7 | 3 |
Magnesium sulfate (n = 10) | 0 | 7 | 3 |
Ketamine (n = 10) | 0 | 9 | 1 |
Dexmedetomidine (n = 10) | 3 | 7 | 0 |